Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

Summary

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma is a clinical trial^[1].

Key Facts

• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma is in the country of United States^[2].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's instance of is recorded as clinical trial^[3].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's start time is recorded as +1996-11-30T00:00:00Z^[4].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's end time is recorded as +2007-11-30T00:00:00Z^[5].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's sponsor is recorded as The University of Texas MD Anderson Cancer Center^[6].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's main subject is recorded as osteosarcoma^[7].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's number of participants is recorded as {'unit': '1', 'amount': '+30'}^[8].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's title is recorded as Phase II Study of Recombinant Interferon Alpha and Etoposide in Patients With Relapsed Osteosarcoma^[9].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+5'}^[10].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's ClinicalTrials.gov ID is recorded as NCT00504140^[11].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[12].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's research intervention is recorded as etoposide^[13].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's research intervention is recorded as etoposide phosphate^[14].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's research intervention is recorded as interferon-alpha^[15].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's clinical trial phase is recorded as phase II clinical trial^[16].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's research subject recruitment status is recorded as completed^[17].
• Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma's study type is recorded as interventional study^[18].